Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Map3k2 (mitogen activated protein kinase kinase kinase 2) Rattus norvegicus
Analyze
Symbol: Map3k2
Name: mitogen activated protein kinase kinase kinase 2
Description: Exhibits MAP kinase kinase kinase activity. Involved in protein phosphorylation. Localizes to the cytosol and nucleus. Orthologous to human MAP3K2 (mitogen-activated protein kinase kinase kinase 2); PARTICIPATES IN c-Jun N-terminal kinases MAPK signaling pathway; Erk5 MAPK signaling pathway; gonadotropin-releasing hormone signaling pathway; INTERACTS WITH 3-chloropropane-1,2-diol; ammonium chloride; bisphenol A.
Type: protein-coding
RefSeq Status: VALIDATED
Also known as: Mekk2; mitogen-activated protein kinase kinase kinase 2
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.01824,961,250 - 25,025,488 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.01824,676,280 - 24,740,723 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41824,606,219 - 24,672,732 (+)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.11824,680,069 - 24,682,550 (+)NCBI
Celera1823,559,225 - 23,623,916 (+)NCBICelera
Cytogenetic Map18p12NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations
Gene Ontology Annotations
Molecular Pathway Annotations
References - curated
References - uncurated

Genomics

Comparative Map Data
Position Markers
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome
Promoters

Strain Variation

Strain Sequence Variants (Rnor 5.0)
Damaging Variants

Additional Information

External Database Links
Nomenclature History
RGD Curation Notes
 
More on Map3k2
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

CRRD Object Information
CRRD ID: 620967
Created: 2002-08-06
Species: Rattus norvegicus
Last Modified: 2019-08-20
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.